[Surveillance and cost-effectiveness of colonoscopy in asymptomatic increased risk subjects of colorectal cancer: Ferrara experience].
Colorectal cancer represents the second leading cause of cancer deaths in western countries with elevated costs for health service. It's very important to develop screening and surveillance programs for cancer prevention with "cost-effective" means. We present a surveillance program with colonoscopy focused on first degree relatives of CRC patients. Colonoscopy is a "cost-effective" mean of screening for high risk subjects.
Matarese
Vincenzo
V
U.O. Gastroenterologia ed Endoscopia Digestiva, Azienda Ospedaliera Universitaria S. Anna, Ferrara. mtv@unife.it
Pezzoli
Alessandro
A
Trevisani
Lucio
L
Boccia
Sergio
S
Brancaleoni
Massimiliano
M
Simone
Loredana
L
Feo
Carlo
C
Gullini
Sergio
S
D000328:Adult; D000368:Aged; D003113:Colonoscopy / Q000191:economics*; D015179:Colorectal Neoplasms / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008403:Mass Screening / Q000191:economics* / Q000379:methods; D008875:Middle Aged; D011159:Population Surveillance; D018570:Risk Assessment; D012307:Risk Factors